Issue link: https://htpgraphics.uberflip.com/i/116750
Commercialising the Inhibitor SCENARIOS assistance and it is hoping that there may be a way of allowing such assistance in the terms of the agreement with IPP. Lakeland thinks it would be a good idea to register the trade mark AROINHIB in respect of pharmaceutical goods. Given that IPP's marketing team suggested the name AROINHIB, IPP would like to be able to use the name freely in relation to the treatment e.g. on marketing materials. Both Lakeland and IPP are keen to ensure that the treatment is protected and are hoping to apply for a patent in respect of the treatment as soon as possible. Lakeland thinks it is likely to have difficulty in funding a patent application, but is concerned that, if it is not registered as the owner of the patent, it will lose control of the use of the drug. Remember that you are putting yourself in the position of Brian Hodgson, Prof. Table and Lakeland. Think back to the information you picked up from the Licensing Guide and perhaps refresh your memory by having a quick scan of it. Then, using the example licence structure set out overleaf, put together a list of key terms for a licence agreement between Lakeland and IPP. This has been taken from the Licensing Guide. EXAMPLE OF LICENCE STRUCTURE PARTIES n Ensure the Licensor(s) and Licensee are correctly identified, with company numbers, where companies. BACKGROUND n Set the scene of how the IP was created; how the IP is being licensed and for what purpose. OPERATIVE PROVISIONS DEFINITIONS Insert definitions to make the contract more user friendly. In particular, ensure you properly define the Technology, Field of Use, Territory and Royalties! 29